Good Response to Tofacitinib in Refractory Amyopathic Dermatomyositis

Actas Dermosifiliogr (Engl Ed). 2021 Apr;112(4):374-376. doi: 10.1016/j.ad.2019.07.016. Epub 2020 Oct 27.

[Article in English, Spanish]

Authors

A Crespo Cruz¹, J Del Boz², C Romero Gómez³

Affiliations

¹ Servicio de Dermatología, Hospital Universitario Nuestra Señora de Valme, Sevilla, España.
² Servicio de Dermatología, Hospital Costa del Sol, Marbella, Málaga, España. Electronic address: javierdelboz@yahoo.es.
³ Servicio de Medicina Interna, Hospital Costa del Sol, Marbella, Málaga, España.

PMID: 33127420
DOI: 10.1016/j.ad.2019.07.016

No abstract available

Publication types

Case Reports

MeSH terms

Dermatomyositis* / drug therapy
Humans
Piperidines
Pyrimidines / therapeutic use
Pyrroles / therapeutic use

Substances

Piperidines
Pyrimidines
Pyrroles
tofacitinib

Supplementary concepts

Amyopathic dermatomyositis